NCT00025584View on ClinicalTrials.gov

PS-341 in Treating Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

August 31, 2004

Conditions
Recurrent Breast CancerStage IV Breast Cancer
Interventions
DRUG

bortezomib

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00025584 - PS-341 in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter